![François-Maurice Garnier](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
François-Maurice Garnier
Director/Miembro de la Junta en EPIZYME, INC. .
Perfil
François-Maurice Garnier is currently the Chairman at Ipsen Consumer Healthcare SAS, the Director at Epizyme, Inc., and the Director at Union des Fabricants.
He is also the Director at Albireo Pharma, Inc. starting in 2023.
Previously, he served as the Executive Vice President & General Counsel at Ipsen SA and as the International General Counsel at Pfizer Inc. Mr. Garnier's former positions include Managing Director at Ipsen Pharma SAS, Manager-International Contracts at Les Laboratoires Servier SAS from 1989 to 1995, Chief Counsel-Europe at Aventis Animal Nutrition SA, and Associate Counsel-United States at Rhone Poulenc Rorer from 1996 to 1999.
He obtained his undergraduate degree from Université Paris II Panthéon Assas.
Cargos activos de François-Maurice Garnier
Empresas | Cargo | Inicio |
---|---|---|
IPSEN | Consejero General | 05/01/2015 |
PFIZER, INC. | Consejero General | 01/01/2003 |
EPIZYME, INC. | Director/Miembro de la Junta | 12/08/2022 |
ALBIREO PHARMA, INC. | Director/Miembro de la Junta | 02/03/2023 |
Union des Fabricants | Director/Miembro de la Junta | - |
Ipsen Consumer Healthcare SAS
![]() Ipsen Consumer Healthcare SAS Pharmaceuticals: MajorHealth Technology Part of Scorpius SAS, Ipsen Consumer Healthcare SAS operates as a French biopharmaceutical company. The company is based in Boulogne-Billancourt, France. The company was founded in 2004. Axelle Arnault de la Ménardière has been the CEO of the company since 2020. Ipsen Consumer Healthcare was acquired by Laboratoires Mayoly Spindler SAS from Ipsen SA on July 28, 2022 for $401.36 million. | Presidente | 21/05/2019 |
Antiguos cargos conocidos de François-Maurice Garnier.
Empresas | Cargo | Fin |
---|---|---|
Aventis Animal Nutrition SA
![]() Aventis Animal Nutrition SA Agricultural Commodities/MillingProcess Industries Aventis Animal Nutrition SA manufactures nutritional feed additives for animal feed. The company is headquartered in Paris, France. | Consejero General | 01/01/2001 |
Les Laboratoires Servier SAS
![]() Les Laboratoires Servier SAS Pharmaceuticals: MajorHealth Technology Les Laboratoires Servier SAS manufactures medicines for the treatment of diabetes, venous disease, and cancer. It also offers pharmaceutical products for cardiovascular illnesses such as hypertension, heart failure, and stroke. The company was founded by Jacques Servier in 1954 and is headquartered in Suresnes, France. | Corporate Officer/Principal | 01/09/1995 |
Rhone Poulenc Rorer
![]() Rhone Poulenc Rorer Chemicals: SpecialtyProcess Industries Part of Solvay SA, Rhone Poulenc Rorer is a French pharmaceutical company that manufactures and distributes pharmaceutical products. | Consejero General | - |
░░░░░ ░░░░░░ ░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
Formación de François-Maurice Garnier.
Université Paris II Panthéon Assas | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas cotizadas | 2 |
---|---|
IPSEN | Health Technology |
PFIZER, INC. | Health Technology |
Empresas privadas | 8 |
---|---|
Aventis Animal Nutrition SA
![]() Aventis Animal Nutrition SA Agricultural Commodities/MillingProcess Industries Aventis Animal Nutrition SA manufactures nutritional feed additives for animal feed. The company is headquartered in Paris, France. | Process Industries |
Ipsen Pharma SAS
![]() Ipsen Pharma SAS Pharmaceuticals: MajorHealth Technology Ipsen Pharma SAS is a biopharmaceutical company that develops medicines in oncology, neuroscience and rare diseases. The company was founded by Henri Beaufour in 1929 and is headquartered in Boulogne-Billancourt, France. | Health Technology |
Union des Fabricants | |
Rhone Poulenc Rorer
![]() Rhone Poulenc Rorer Chemicals: SpecialtyProcess Industries Part of Solvay SA, Rhone Poulenc Rorer is a French pharmaceutical company that manufactures and distributes pharmaceutical products. | Process Industries |
Les Laboratoires Servier SAS
![]() Les Laboratoires Servier SAS Pharmaceuticals: MajorHealth Technology Les Laboratoires Servier SAS manufactures medicines for the treatment of diabetes, venous disease, and cancer. It also offers pharmaceutical products for cardiovascular illnesses such as hypertension, heart failure, and stroke. The company was founded by Jacques Servier in 1954 and is headquartered in Suresnes, France. | Health Technology |
Ipsen Consumer Healthcare SAS
![]() Ipsen Consumer Healthcare SAS Pharmaceuticals: MajorHealth Technology Part of Scorpius SAS, Ipsen Consumer Healthcare SAS operates as a French biopharmaceutical company. The company is based in Boulogne-Billancourt, France. The company was founded in 2004. Axelle Arnault de la Ménardière has been the CEO of the company since 2020. Ipsen Consumer Healthcare was acquired by Laboratoires Mayoly Spindler SAS from Ipsen SA on July 28, 2022 for $401.36 million. | Health Technology |
Epizyme, Inc.
![]() Epizyme, Inc. BiotechnologyHealth Technology Epizyme, Inc. is a clinical-stage biopharmaceutical company. The firm engages in the discovery, development, and commercialization of novel epigenetic medicines for cancer and other diseases. Its product pipeline is lead by, tazemetostat which targets Non-Hodgkin Lymphoma, molecularly defined solid tumors, non-small-cell lung carcinoma, molecularly targeted tumors, and ovarian cancer. The firm also develops pinometostat for genetically defined acute leukemia, and EZM8266 for sickle cell disease. The company was founded by Robert Horvitz and Zhang Yi on November 1, 2007 and is headquartered in Cambridge, MA. | Health Technology |
Albireo Pharma, Inc.
![]() Albireo Pharma, Inc. Pharmaceuticals: MajorHealth Technology Albireo Pharma, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of novel bile acid modulators for the treatment of orphan pediatric liver diseases and gastrointestinal disorders. Its pipeline products include Odevixibat, A3384, and Elobixibat. The company was founded by Jan Peter Mattsson and Per-Göran Gillberg on December 8, 2003 and is headquartered in Boston, MA. | Health Technology |
- Bolsa de valores
- Insiders
- François-Maurice Garnier